Genus plc Share Price

Equities

GNS

GB0002074580

Biotechnology & Medical Research

Market Closed - London S.E. 09:05:01 26/04/2024 pm IST 5-day change 1st Jan Change
1,736 GBX +1.88% Intraday chart for Genus plc +1.05% -20.00%

Financials

Sales 2024 * 675M 843M 70.26B Sales 2025 * 712M 889M 74.13B Capitalization 1.14B 1.42B 119B
Net income 2024 * 24M 29.98M 2.5B Net income 2025 * 43M 53.71M 4.48B EV / Sales 2024 * 2.04 x
Net Debt 2024 * 238M 297M 24.75B Net Debt 2025 * 209M 261M 21.79B EV / Sales 2025 * 1.89 x
P/E ratio 2024 *
48 x
P/E ratio 2025 *
27.4 x
Employees 3,500
Yield 2024 *
1.84%
Yield 2025 *
1.99%
Free-Float 99.31%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.88%
1 week+1.05%
Current month-1.64%
1 month-4.46%
3 months-25.88%
6 months-16.05%
Current year-20.00%
More quotes
1 week
1 644.04
Extreme 1644.04
1 780.00
1 month
1 644.04
Extreme 1644.04
1 842.00
Current year
1 478.00
Extreme 1478
2 378.00
1 year
1 478.00
Extreme 1478
2 787.32
3 years
1 478.00
Extreme 1478
6 310.00
5 years
1 478.00
Extreme 1478
6 310.00
10 years
995.50
Extreme 995.5
6 310.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 02/23/02
Director of Finance/CFO - 13/20/13
Chief Operating Officer - 01/11/01
Members of the board TitleAgeSince
Director/Board Member 71 01/18/01
Chairman 67 01/20/01
Director of Finance/CFO - 13/20/13
More insiders
Date Price Change Volume
26/24/26 1,736 +1.88% 39,996
25/24/25 1,704 +0.24% 294,526
24/24/24 1,700 -2.86% 92,920
23/24/23 1,750 +1.39% 159,725
22/24/22 1,726 +0.47% 85,500

Delayed Quote London S.E., April 26, 2024 at 09:05 pm IST

More quotes
Genus plc is a United Kingdom-based animal protein genetics company. The Company supplies breeding animals with desirable characteristics for farmers, enabling them to produce quality meat and milk. Its segments include Genus PIC, Genus ABS and Genus Research and Development. The Genus PIC segment is engaged in the porcine sales business. The Genus ABS segment is engaged in the bovine sales business. Its bovine genetics business sells dairy and beef bull semen and embryos from its superior cattle, which are sold to farmers to breed their cows through artificial insemination. Its porcine genetics business sells genetically superior breeding pigs and semen to farmers, so they can breed commercial pigs with desirable characteristics for pork production. It also provides technical services and advice to farmers, to maximize the performance of its breeding animals in their farms. The Company has supply chain and distribution networks in over 80 countries.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
17.36 GBP
Average target price
29.62 GBP
Spread / Average Target
+70.59%
Consensus

Annual profits - Rate of surprise